Insmed (INSM) PT Raised to $40 at BofA Securities

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH

6. DOCU
7. ASAN
8. NVDA
9. GWRE
10. CIEN

February 23, 2024 6:30 AM EST

Price: $126.29 -0.31%

Rating Summary:
32 Buy, 1 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5

BofA Securities analyst Jason Zemansky raised the price target on Insmed (NASDAQ: INSM) to $40.00 (from $37.00) while maintaining a Buy rating.

Analyst PT Change

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!